# Sitagliptin Treatment in Diabetic COVID-19 Positive Patients

> **NCT04382794** · — · COMPLETED · sponsor: **University of Milan** · enrollment: 338 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Retrospective case-control analysis

## Key facts

- **NCT ID:** NCT04382794
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-14
- **Primary completion:** 2020-06-15
- **Final completion:** 2020-06-15
- **Target enrollment:** 338 (ACTUAL)
- **Last updated:** 2020-07-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04382794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04382794, "Sitagliptin Treatment in Diabetic COVID-19 Positive Patients". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04382794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*